FDA Approves New PARP Inhibitor for BRCA-mutant Ovarian Cancer
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
Category: Policy
On Monday, the U.S. Food and Drug Administration (FDA) announced good news for a subgroup of patients with ovarian...
On Tuesday, President Barack Obama signed H.R. 34, the 21st Century Cures Act (Cures), into law. The expansive bill...
The AACR is a founder and organizing partner of the Rally for Medical Research, which took place for the...
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
Today, the American Association for Cancer Research (AACR) released its sixth annual Cancer Progress Report. The report highlights how...
Michael Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of Arthur G. James Cancer...
Medical journalist Andrew Schorr, a two-time cancer survivor, created Patient Power in 2005 as an online portal for information...
According to the White House, this was the first time a group this expansive and diverse met under a...
Guest Post by Daniel Lee Miller, MD, PhD (@Dan_Lee_Miller) Associate member of the AACR and resident physician in Pathology,...
Researchers have well established that smoking leads to adverse outcomes in cancer patients; however, the specific effects caused by...